Louisville, KY, United States of America

Francesca R Salipur


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francesca R. Salipur: Innovator in Cancer Treatment

Introduction

Francesca R. Salipur is a prominent inventor based in Louisville, Kentucky. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of two patents, her work focuses on enhancing the efficacy of DNMT1 inhibitors in cancer therapy.

Latest Patents

Francesca's latest patents include "Compositions and methods for modulating DNMT1 inhibitor activity" and "Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the marker." The first patent discusses methods for attenuating DNMT1 inhibitor activity in animals by administering an antioxidant. This invention is particularly relevant for animals undergoing cancer treatment. The second patent provides methods for predicting the efficacy of DNMT1 inhibitor treatments in cancer patients. It includes identifying subjects more likely to respond to such treatments based on the level of SOX9 in their cells.

Career Highlights

Francesca R. Salipur is affiliated with the University of Louisville Research Foundation, Inc. Her work has been instrumental in advancing cancer treatment methodologies. She has developed innovative approaches that combine DNMT1 inhibitors with antioxidants to improve therapeutic outcomes.

Collaborations

Francesca collaborates with notable colleagues, including Paula J. Bates and Elsa Merit Reyes-Reyes. These partnerships enhance her research and contribute to the development of effective cancer treatments.

Conclusion

Francesca R. Salipur is a dedicated inventor whose work in cancer treatment is paving the way for more effective therapies. Her innovative patents reflect her commitment to improving patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…